Mounjaro 5mg Injection: What Changes at This Stage of Treatment

Step 1: Why 2.5mg comes first, and what 5mg is actually for

The titration schedule starts at 2.5mg for a straightforward reason: tirzepatide is a potent medicine, and giving the body a month at a lower dose before increasing it substantially reduces the likelihood of severe nausea or vomiting. The 2.5mg starter pen is not expected to produce significant weight loss; its job is adjustment.

The 5mg pen is different. This is the first dose at which appetite suppression tends to become noticeable for most people. Many patients describe feeling full sooner, less preoccupied with food between meals, and less drawn to high-calorie snacking. That shift happens because tirzepatide acts on both GIP and GLP-1 receptors, slowing gastric emptying and influencing the brain's hunger signals, a dual mechanism no other licensed UK weight-loss injection shares. The clinical development work that informed the current schedule was built around this kind of stepwise tolerability.

Whether you move from 2.5mg to 5mg on schedule, or stay longer at the starter dose, is a clinical decision. A prescriber reviews your response before any change is made.

Step 2: Injecting the 5mg pen, the practical routine

The injection method at 5mg is identical to 2.5mg. The Mounjaro KwikPen is pre-filled and pre-set; you do not draw up a dose or adjust the dial. Choose a site (abdomen, outer thigh or upper arm) and rotate the spot each week to avoid irritation at any one area. Inject on the same day each week where possible; if your schedule slips, the Mounjaro 5mg pen guidance and the Patient Information Leaflet both cover the timing window in detail.

Storage matters at every dose. The pen should be kept refrigerated between 2°C and 8°C. There is a limited period during which it can be kept at room temperature, but the exact window is stated in the SmPC and leaflet, not something to estimate from memory. If you are unsure whether a pen has been stored correctly, speak to your prescriber or pharmacist before using it.

The volume contained in a 5mg pen is a question that comes up fairly often; the answer is in the product information rather than something to rely on from secondary sources.

Step 3: Side effects at 5mg and how to manage them

Moving from 2.5mg to 5mg is a dose increase, and the body sometimes needs a short period to adapt. The most commonly reported effects are gastrointestinal: nausea, loose stools, constipation, indigestion, or a general sense of queasiness after eating. These typically peak in the first few days after the increase and ease off within a week or two for most people.

Practical steps that tend to help: eating smaller portions slowly, staying well hydrated, avoiding rich or fatty meals in the days immediately after your injection, and giving yourself a moment after eating rather than eating on the go. None of this replaces advice from your clinical team, who can adjust the plan if side effects are making the dose hard to tolerate.

The NHS has clear patient-level guidance on tirzepatide's side effects and what to watch for. Urgent medical attention is needed for severe, persistent abdominal pain that radiates to the back, a symptom associated with pancreatitis, which the MHRA has identified as an infrequent but serious risk with GLP-1 medicines. Report any unexpected or troubling effects to your prescriber and, where appropriate, through the MHRA Yellow Card scheme.

Step 4: Staying at 5mg or moving to 7.5mg

Some people remain at 5mg for longer than the standard four weeks if side effects are still present or if their prescriber considers it the right clinical call. There is no obligation to titrate to the next dose by a fixed date. Treatment is individual.

When the time comes to consider moving up, the 7.5mg dose is the next step. The evidence from the SURMOUNT-1 trial, which enrolled thousands of adults with obesity and ran for 72 weeks, showed that average weight loss increased progressively with dose; those who reached the higher doses tended to see the greatest reductions. That data informs why prescribers typically encourage continued titration in people who are tolerating treatment well, but always with a clinical review at each stage.

For context on how private treatment is priced across the titration journey, the background on Mounjaro's UK pricing is worth reading before you start. Costs do vary by dose and provider, and understanding what a legitimate price includes (prescription, clinical oversight, delivery) helps set expectations early. One transparent summary of what is included at each stage is available on the 5mg dose overview page.

If you are considering starting treatment or have questions about where you are in the process, a consultation with our prescribers is the right next step. Speak to our prescribers through the weight-loss treatments page, the review is free, happens the same day a clinician receives your answers, and there is no pressure to proceed.